Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases.
<h4>Background</h4>No selection criteria for helical tomotherapy (HT) based stereotactic ablative radiotherapy (SABR) to treat early stage non-small cell lung cancer (NSCLC) or solitary lung metastases has been established. In this study, we investigate the dosimetric selection criteria...
Guardado en:
Autores principales: | Alexander Chi, Zhongxing Liao, Nam P Nguyen, Jiahong Xu, James S Welsh, Si Young Jang, Carol Howe, Ritsuko Komaki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b66d99fb67fc49949f9abb11f83a439c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.
por: Benjamin Mou, et al.
Publicado: (2014) -
Dosimetric Comparison of Helical Tomotherapy and Intensity-Modulated Proton Therapy in Hippocampus- and Scalp-Sparing Whole Brain Radiotherapy
por: Taiki Takaoka MD, PhD, et al.
Publicado: (2021) -
Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases
por: Davide Scafa, et al.
Publicado: (2021) -
Treatment outcomes of re-irradiation using stereotactic ablative radiotherapy to lung: a propensity score matching analysis
por: Tae Hoon Lee, et al.
Publicado: (2021) -
Dosimetric Comparison of Helical Tomotherapy, Volume-Modulated Arc Therapy, and Fixed-Field Intensity-Modulated Radiation Therapy in Locally Advanced Nasopharyngeal Carcinoma
por: Shan Lu, et al.
Publicado: (2021)